J0121 HCPCS code: Injection, omadacycline, 1 mg
J0121 is the HCPCS Level II code for injection, omadacycline, 1 mg. In 2024 Medicare paid an average of $2.96 per service for J0121 across 858,861 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 200 per day on outpatient hospital claims. Medicare volume rose 90% from 2022 to 2024 (452,931 to 858,861 services). In 2024, about 111 clinicians billed Medicare for J0121 for 413 beneficiaries; Florida, Texas, Georgia accounted for 90% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2019-10-01 |
| Last action effective | 2019-10-01 |
Who bills J0121 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 111 |
| Medicare beneficiaries | 413 |
| States with claims | 5 |
| Share of services in top 3 states (Florida, Texas, Georgia) | 90% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0121, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 452,931 | 297 | $3.32 | $2.65 |
| 2023 | 563,567 | 356 | $3.59 | $2.85 |
| 2024 | 858,861 | 413 | $3.72 | $2.96 |
States with the most J0121 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 404,342 | $2.96 |
| Texas | 162,009 | $2.95 |
| Georgia | 148,000 | $2.96 |
| Michigan | 44,302 | $3.00 |
| Indiana | 36,100 | $2.96 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 200 | Prescribing Information |
| practitioner claims | 200 | Prescribing Information |
What changed for J0121
- 2019-10-01: J0121 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0121?
J0121 is the HCPCS Level II code for injection, omadacycline, 1 mg. Short descriptor: "Inj., omadacycline, 1 mg".
How much does Medicare pay for J0121?
In 2024, the average Medicare payment was $2.96 per service (average allowed $3.72).
Does Medicare cover J0121?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0121 can be billed per day?
200 on outpatient hospital claims; 200 on practitioner claims (NCCI medically unlikely edits).
Related J01 codes
- J0120 — Injection, tetracycline, up to 250 mg
- J0122 — Injection, eravacycline, 1 mg
- J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 — Injection abciximab, 10 mg
- J0131 — Injection, acetaminophen, not otherwise specified,10 mg
- J0132 — Injection, acetylcysteine, 100 mg
- J0133 — Injection, acyclovir, 5 mg
- J0134 — Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg
- J0135 — Injection, adalimumab, 20 mg
- J0136 — Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg
- J0137 — Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg
- J0138 — Injection, acetaminophen 10 mg and ibuprofen 3 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0121
- Watch J0121 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0121
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.